Gsa Capital Partners LLP Palisade Bio, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.43 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$0.81 - $1.51 $8,467 - $15,785
-10,454 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.3 - $2.96 $13,590 - $30,943
10,454 New
10,454 $14,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $251M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email